Aether Biomachines
unknown
unknown
Stage
1
Investors
About
Aether Biomachines repurposes enzymes to create entirely new compounds by applying enzyme engineering and synthetic biology approaches. The company focuses on developing enzyme-driven platforms to discover and produce novel molecules.
Explore Aether Biomachines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.